BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 21633304)

  • 1. Defining prognostic variables in recurrent endometrioid endometrial cancer: a 15-year single-institution review.
    Esselen KM; Boruta DM; del Carmen M; Schorge JO; Goodman A; Growdon WB
    Int J Gynecol Cancer; 2011 Aug; 21(6):1078-83. PubMed ID: 21633304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between lymphovascular space invasion, nodal recurrence, and survival in patients with surgical stage I endometrioid endometrial adenocarcinoma.
    Veade AE; Foote J; Ehrisman J; Broadwater G; Davidson BA; Lee PS; Secord AA; Berchuck A; Havrilesky LJ
    World J Surg Oncol; 2019 May; 17(1):80. PubMed ID: 31077193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of Survival After Recurrence in Women With Early-Stage Endometrial Carcinoma.
    Xu Y; Burmeister C; Hanna RK; Munkarah A; Elshaikh MA
    Int J Gynecol Cancer; 2016 Jul; 26(6):1137-42. PubMed ID: 27206283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
    Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
    Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant Treatment after Surgery in Stage IIIA Endometrial Adenocarcinoma.
    Yoon MS; Huh SJ; Kim HJ; Kim YS; Kim YB; Kim JY; Lee JH; Kim HJ; Cha J; Kim JH; Kim J; Yoon WS; Choi JH; Chun M; Choi Y; Lee KK; Kim M; Jeong JU; Chang SK; Park W
    Cancer Res Treat; 2016 Jul; 48(3):1074-83. PubMed ID: 26511800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer].
    Wang Y; Yu M; Yang JX; Cao DY; Zhang Y; Shen K; You Y
    Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):816-822. PubMed ID: 30585019
    [No Abstract]   [Full Text] [Related]  

  • 7. Survival analysis of endometrial cancer patients with positive lymph nodes.
    Brown AP; Gaffney DK; Dodson MK; Soisson AP; Belnap TW; Alleman K; Sause WT
    Int J Gynecol Cancer; 2013 Jun; 23(5):861-8. PubMed ID: 23598890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphadenectomy in women with endometrial cancer: aspiration and reality from a radiation oncologist's point of view.
    Foerster R; Kluck R; Arians N; Rieken S; Rief H; Adeberg S; Bostel T; Schlampp I; Debus J; Lindel K
    Radiat Oncol; 2015 Jul; 10():147. PubMed ID: 26179059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adult Comorbidity Evaluation 27 score as a predictor of survival in endometrial cancer patients.
    Binder PS; Peipert JF; Kallogjeri D; Brooks RA; Massad LS; Mutch DG; Powell MA; Thaker PH; McCourt CK
    Am J Obstet Gynecol; 2016 Dec; 215(6):766.e1-766.e9. PubMed ID: 27457116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant therapy in stage III endometrial cancer: treatment outcomes and survival. a single-institution retrospective study.
    Kuku S; Williams M; McCormack M
    Int J Gynecol Cancer; 2013 Jul; 23(6):1056-64. PubMed ID: 23765205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of lymph node ratio on survival in stage IIIC endometrioid endometrial cancer: a Turkish Gynecologic Oncology Group study.
    Ayhan A; Topfedaisi Ozkan N; Öz M; Kimyon Comert G; Firat Cuylan Z; Çoban G; Turkmen O; Erdem B; Şahin H; Akbayır Ö; Dede M; Turan AT; Celik H; Güngör T; Haberal A; Arvas M; Meydanli MM
    J Gynecol Oncol; 2018 Jul; 29(4):e48. PubMed ID: 29770619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of tumor grade on survival end points and patterns of recurrence of 949 patients with early-stage endometrioid carcinoma: a single institution study.
    Gayar OH; Patel S; Schultz D; Mahan M; Rasool N; Elshaikh MA
    Int J Gynecol Cancer; 2014 Jan; 24(1):97-101. PubMed ID: 24264358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrence patterns and prognostic factors in lymphovascular space invasion-positive endometrioid endometrial cancer surgically confined to the uterus.
    Sahin H; Meydanli MM; Sari ME; Kocaman E; Cuylan ZF; Yalcin I; Coban G; Özen Ö; Sirvan L; Güngör T; Ayhan A
    Taiwan J Obstet Gynecol; 2019 Jan; 58(1):82-89. PubMed ID: 30638487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors for tumor recurrence in endometrioid endometrial cancer stages IA and IB.
    Han KH; Kim HS; Lee M; Chung HH; Song YS
    Medicine (Baltimore); 2017 May; 96(21):e6976. PubMed ID: 28538399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphovascular space invasion (LVSI) is an isolated poor prognostic factor for recurrence and survival among women with intermediate- to high-risk early-stage endometrioid endometrial cancer.
    Weinberg LE; Kunos CA; Zanotti KM
    Int J Gynecol Cancer; 2013 Oct; 23(8):1438-45. PubMed ID: 24257558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of recurrence in 1988 FIGO stage IC endometrioid endometrial cancer.
    Long KC; Zhou Q; Hensley ML; Alektiar KM; Gomez J; Gardner GJ; Chi DS; Barakat RR; Abu-Rustum NR
    Gynecol Oncol; 2012 Apr; 125(1):99-102. PubMed ID: 22112609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent early stage endometrial cancer: Patterns of recurrence and results of salvage therapy.
    Francis SR; Ager BJ; Do OA; Huang YJ; Soisson AP; Dodson MK; Werner TL; Sause WT; Grant JD; Gaffney DK
    Gynecol Oncol; 2019 Jul; 154(1):38-44. PubMed ID: 31029507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparable outcome between endometrioid and non-endometrioid tumors in patients with early-stage high-grade endometrial cancer.
    Reynaers EA; Ezendam NP; Pijnenborg JM
    J Surg Oncol; 2015 May; 111(6):790-4. PubMed ID: 25900897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis for endometrial cancer patients treated with systematic pelvic and para-aortic lymphadenectomy followed by platinum-based chemotherapy.
    Sueoka K; Umayahara K; Abe A; Usami T; Yamamoto A; Nomura H; Matoda M; Okamoto S; Omatsu K; Kondo E; Kato K; Takeshima N
    Int J Gynecol Cancer; 2015 Jan; 25(1):81-6. PubMed ID: 25347094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L1 Cell Adhesion Molecule as a Predictor of Disease-Specific Survival and Patterns of Relapse in Endometrial Cancer.
    Pasanen A; Tuomi T; Isola J; Staff S; Bützow R; Loukovaara M
    Int J Gynecol Cancer; 2016 Oct; 26(8):1465-71. PubMed ID: 27648714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.